TY  - JOUR
A1  - Pluta, Natalie
A1  - Hoffjan, Sabine
A1  - Zimmer, Frederic
A1  - Köhler, Cornelia
A1  - Lücke, Thomas
A1  - Mohr, Jennifer
A1  - Vorgerd, Matthias
A1  - Nguyen, Hoa Huu Phuc
A1  - Atlan, David
A1  - Wolf, Beat
A1  - Zaum, Ann-Kathrin
A1  - Rost, Simone
T1  - Homozygous inversion on chromosome 13 involving SGCG detected by short read whole genome sequencing in a patient suffering from limb-girdle muscular dystrophy
JF  - Genes
N2  - New techniques in molecular genetic diagnostics now allow for accurate diagnosis in a large proportion of patients with muscular diseases. Nevertheless, many patients remain unsolved, although the clinical history and/or the muscle biopsy give a clear indication of the involved genes. In many cases, there is a strong suspicion that the cause must lie in unexplored gene areas, such as deep-intronic or other non-coding regions. In order to find these changes, next-generation sequencing (NGS) methods are constantly evolving, making it possible to sequence entire genomes to reveal these previously uninvestigated regions. Here, we present a young woman who was strongly suspected of having a so far genetically unsolved sarcoglycanopathy based on her clinical history and muscle biopsy. Using short read whole genome sequencing (WGS), a homozygous inversion on chromosome 13 involving SGCG and LINC00621 was detected. The breakpoint in intron 2 of SGCG led to the absence of γ-sarcoglycan, resulting in the manifestation of autosomal recessive limb-girdle muscular dystrophy 5 (LGMDR5) in the young woman.
KW  - inversion
KW  - sarcoglycanopathy
KW  - whole genome sequencing (WGS)
KW  - next generation sequencing (NGS)
KW  - LGMDR5
KW  - muscle disease
KW  - genetic diagnostics
Y1  - 2022
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-288122
SN  - 2073-4425
VL  - 13
IS  - 10
ER  - 
TY  - JOUR
A1  - Hoppe, Kerstin
A1  - Sartorius, Tina
A1  - Chaiklieng, Sunisa
A1  - Wietzorrek, Georg
A1  - Ruth, Peter
A1  - Jurkat-Rott, Karin
A1  - Wearing, Scott
A1  - Lehmann-Horn, Frank
A1  - Klingler, Werner
T1  - Paxilline Prevents the Onset of Myotonic Stiffness in Pharmacologically Induced Myotonia: A Preclinical Investigation
JF  - Frontiers in Physiology
N2  - Reduced Cl\(^{-}\) conductance causes inhibited muscle relaxation after forceful voluntary contraction due to muscle membrane hyperexcitability. This represents the pathomechanism of myotonia congenita. Due to the prevailing data suggesting that an increased potassium level is a main contributor, we studied the effect of a modulator of a big conductance Ca\(^{2+}\)- and voltage-activated K\(^{+}\) channels (BK) modulator on contraction and relaxation of slow- and high-twitch muscle specimen before and after the pharmacological induction of myotonia. Human and murine muscle specimens (wild-type and BK\(^{-/-}\)) were exposed to anthracene-9-carboxylic acid (9-AC) to inhibit CLC-1 chloride channels and to induce myotonia in-vitro. Functional effects of BK-channel activation and blockade were investigated by exposing slow-twitch (soleus) and fast-twitch (extensor digitorum longus) murine muscle specimens or human musculus vastus lateralis to an activator (NS1608) and a blocker (Paxilline), respectively. Muscle-twitch force and relaxation times (T\(_{90/10}\)) were monitored. Compared to wild type, fast-twitch muscle specimen of BK\(^{-/-}\) mice resulted in a significantly decreased T\(_{90/10}\) in presence of 9-AC. Paxilline significantly shortened T\(_{90/10}\) of murine slow- and fast-twitch muscles as well as human vastus lateralis muscle. Moreover, twitch force was significantly reduced after application of Paxilline in myotonic muscle. NS1608 had opposite effects to Paxilline and aggravated the onset of myotonic activity by prolongation of T\(_{90/10}\). The currently used standard therapy for myotonia is, in some individuals, not very effective. This in vitro study demonstrated that a BK channel blocker lowers myotonic stiffness and thus highlights its potential therapeutic option in myotonia congenital (MC).
KW  - paxilline
KW  - NS1608
KW  - repetitive firing
KW  - myotonia congenita
KW  - muscle disease
KW  - BK channel
Y1  - 2020
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-218152
VL  - 11
ER  -